NEW YORK (Reuters Health) - Children who develop problems with memory, attention and behavior after cancer treatment may gain some long-term benefit from a medication commonly used for attention-deficit hyperactivity disorder (ADHD), a small clinical trial suggests.
No comments:
Post a Comment